WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001005250) POTASSIUM CALCIUM CITRATE COMPOSITIONS AND METHODS FOR PRODUCTION
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2001/005250 International Application No.: PCT/US2000/040436
Publication Date: 25.01.2001 International Filing Date: 19.07.2000
Chapter 2 Demand Filed: 20.02.2001
IPC:
A23L 1/304 (2006.01) ,A61K 33/06 (2006.01)
Applicants: MISSION PHARMACAL COMPANY[US/US]; 10999 IH 10 West Suite 1000 San Antonio, TX 78230, US
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEMS[US/US]; 201 West 7th Street Austin, TX 78701, US
Inventors: PAK, Charles, Y., C.; US
ALEXANDRIDES, George; US
WALSDORF, Neill, B.; US
Agent: HANOR, Charles, W. ; Akin, Gump, Strauss, Hauer & Feld, L.L.P. 300 Convent Street San Antonio, TX 78205, US
Priority Data:
09/356,64919.07.1999US
Title (EN) POTASSIUM CALCIUM CITRATE COMPOSITIONS AND METHODS FOR PRODUCTION
(FR) COMPOSITIONS DE CITRATE DE POTASSIUM ET DE CALCIUM ET METHODES DE PRODUCTION
Abstract: front page image
(EN) A composition useful as a dietary supplement for providing potassium, calcium, and citrate is presented, as well as processes for producing the composition, and methods for using the composition as a dietary supplement. Administration of the composition counters bone loss associated with aging or menopause by providing bioavailable calcium and, simultaneously, delivering alkali load. In addition, administration of the composition produces a substantial increase in urinary citrate, which counters kidney-stone formation.
(FR) L'invention concerne une composition utile comme supplément diététique contenant du potassium, du calcium et du citrate. L'invention concerne également des procédés de production de cette composition et des méthodes d'utilisation de cette composition comme supplément diététique. L'administration de cette composition permet de lutter contre la perte osseuse due au vieillissement et à la ménopause par l'apport d'un calcium biodisponible et, simultanément, par l'apport d'une charge alcaline. En outre, l'administration de cette composition provoque un accroissement sensible des taux de citrate urinaire, qui empêche la formation de calculs rénaux.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, UZ, VN, YU, ZA, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)